Future-Proofing Pharma & Personal Care: How Life Cycle Assessments & Carbon Footprinting Drive Real Change

Complimentary
Learning Level: Intermediate
Time: 1100 - 1230 ET 
Session Length: 1.5 hour

As climate change intensifies and regulatory pressure grows, the pharmaceutical industry must urgently address its environmental footprint. This webinar, organized by the ISPE Sustainability Community of Practice (CoP), gathers experts from leading pharmaceutical companies to explore Life Cycle Assessment (LCA) as a key tool for measuring and managing product carbon footprints. The session will cover LCA fundamentals, industry efforts to standardize methodologies, challenges in certification, and a capsule case study demonstrating practical sustainability improvements.

Learning Objectives

  • Understand how Life Cycle Assessments supports environmental impact measurement and reduction in pharma manufacturing.
  • To highlight the key challenges in performing Life Cycle Assessments and share the opportunities they reveal for improving product sustainability.
  • Examine how certified carbon footprint methods and real-world case studies drive sustainability strategies and stakeholder engagement.

Register Now!


Speakers

Thomas Gosmann
Sustainability Lead Global Pharma Engineering
Bayer AG
Sophie Azevedo
Global Environmental Life Cycle Assessment Manager
Takeda
Aiperi Otunchieva
LCA Expert
Arcondis
Sofia Sotiropoulou
Senior Director of Sustainability & Climate Innovation
Lonza Capsules & Health Ingredients (CHI)
Stephanie Stärkle
Process Engineer
VTU Engineering